193 related articles for article (PubMed ID: 19836067)
61. Association between micronucleus frequency and cervical intraepithelial neoplasia grade in Thinprep cytological test and its significance.
Shi YH; Wang BW; Tuokan T; Li QZ; Zhang YJ
Int J Clin Exp Pathol; 2015; 8(7):8426-32. PubMed ID: 26339413
[TBL] [Abstract][Full Text] [Related]
62. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
[TBL] [Abstract][Full Text] [Related]
63. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
64. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
65. Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions.
Lattario F; Furtado YL; Fonseca R; Silveira FA; do Val IC; Almeida G; Carvalho MG
Int J Gynecol Cancer; 2008; 18(4):785-9. PubMed ID: 17868341
[TBL] [Abstract][Full Text] [Related]
66. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
Zhang Y; Wang X; Ma L; Wang Z; Hu L
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
[TBL] [Abstract][Full Text] [Related]
67. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract][Full Text] [Related]
68. [Diagnostic implications of atypical squamous cells of unknown significance with abnormal DNA ploidy for early cervical lesions].
Mei JH; Xu S; Han YL; Tu Y; Xiong YF; Yu YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):829-32. PubMed ID: 24507102
[TBL] [Abstract][Full Text] [Related]
69. Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia.
Ma L; Fisk JM; Zhang RR; Ulukus EC; Crum CP; Zheng W
Am J Surg Pathol; 2004 Nov; 28(11):1474-84. PubMed ID: 15489651
[TBL] [Abstract][Full Text] [Related]
70. The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells.
Wu MZ; Wang S; Zheng M; Tian LX; Wu X; Guo KJ; Zhang YI; Wu GP
Cell Transplant; 2019 Feb; 28(2):195-200. PubMed ID: 30545241
[TBL] [Abstract][Full Text] [Related]
71. Diagnostic and prognostic significance of image cytometric DNA ploidy measurement in cytological samples of cervical squamous intraepithelial lesions.
Demirel D; Akyürek N; Ramzy I
Cytopathology; 2013 Apr; 24(2):105-12. PubMed ID: 23331643
[TBL] [Abstract][Full Text] [Related]
72. Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.
Lea JS; Coleman R; Kurien A; Schorge JO; Miller DS; Minna JD; Muller CY
Am J Obstet Gynecol; 2004 Mar; 190(3):674-9. PubMed ID: 15041998
[TBL] [Abstract][Full Text] [Related]
73. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
74. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
75. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.
Ivanova T; Petrenko A; Gritsko T; Vinokourova S; Eshilev E; Kobzeva V; Kisseljov F; Kisseljova N
BMC Cancer; 2002 Mar; 2():4. PubMed ID: 11945179
[TBL] [Abstract][Full Text] [Related]
76. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
Wentzensen N; Sherman ME; Schiffman M; Wang SS
Gynecol Oncol; 2009 Feb; 112(2):293-9. PubMed ID: 19054549
[TBL] [Abstract][Full Text] [Related]
77. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
78. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong SM; Kim HS; Rha SH; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
[TBL] [Abstract][Full Text] [Related]
79. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
80. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
